Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 5 51-5, 2005, Pages

  Corbould, Anne ^a,e   Kim, Young Bum ^b   Youngren, Jack F ^c   Pender, Celia ^c   Kahn, Barbara B ^b   Lee, Anna ^a,b   Dunaif, Andrea ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Glucose transport; Glucose transporter 1; Insulin receptor substrate; Myotubes; Polycystic ovary syndrome; Serine phosphorylation

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; SKIN FIBROBLAST;

ADULT; CELLS, CULTURED; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE FIBERS; MUSCLE, SKELETAL; POLYCYSTIC OVARY SYNDROME; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 17444385941     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00361.2004     Document Type: Article

References (52)

1. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, and Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733, 2001.
2. 307. J Biol Chem 275: 9047-9054, 2000.
3. Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VDH, Zierath JR, and Krook A. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 60: 991-998, 2003.
4. Bjornholm M, Kawano Y, Lehtihet M, and Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997.
5. Book CB and Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84: 3110-3116, 1999.
6. Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti J-F, and Vidal H. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52: 1319-1325, 2003.
7. Burks DJ, Font de Mora J, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, and White MF. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407: 377-382, 2000.
8. Ciaraldi TP, Abrams L, Nikoulina S, Mudaliar S, and Henry RR. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 96: 2820-2827, 1995.
9. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, and Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75: 577-583, 1992.
10. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, and Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105: 311-320, 2000.
11. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18: 774-800, 1997.
12. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, and Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41: 1257-1266, 1992.
13. Dunaif A, Wu X, Lee A, and Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281: E392-E399, 2001.
14. Dunaif A, Xia J, Book CB, Schenker E, and Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in polycystic ovarian syndrome. J Clin Invest 96: 801-810, 1995.
15. Eberling P, Koistinen HA, and Koivisto VA. Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett 436: 301-303, 1998.
16. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22: 141-146, 1999.
17. Eisner JR, Dumesic DA, Kemnitz JW, and Abbott DH. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 85: 1206-1210, 2000.
18. Ek I, Arner P, Bergqvist A, Carlström, and Wahrenberg H. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? J Clin Endocrinol Metab 82: 1147-1153, 1997.
19. Ek I, Arner P, Ryden M, Holm C, Thorne A, Hoffstedt J, and Wahrenberg H. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 51: 484-492, 2002.
20. Gaster M, Handberg A, Beck-Nielson H, and Schroder HD. Glucose transporter expression in human skeletal muscle fibers. Am J Physiol Endocrinol Metab 279: E529-E538, 2000.
21. Gaster M, Petersen I, Hojlund K, Poulsen P, and Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects. Evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51: 921-927, 2002.
22. Goodyear LJ, Giorgio F, Sherman LA, Carey J, Smith JR, and Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204, 1995.
23. Greene MW, Sakaue H, Wang L, Alessi DR, and Roth RA. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by serine 312 phosphorylation. J Biol Chem 278: 8199-8211, 2003.
24. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, and Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
25. Henry RR, Abrams L, Nikoulina S, and Ciaraldi TP. Insulin action and glucose metabolism in non-diabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 44: 936-946, 1995.
26. Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, and Nikoulina SE. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. J Clin Invest 98: 1231-1236, 1996.
27. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, and Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668, 1996.
28. Jackson S, Bagstaff SM, Lynn S, Yeaman SJ, Turnbull DM, and Walker M. Decreased insulin responsiveness of glucose uptake in cultured skeletal muscle cells from insulin-resistant non-diabetic relatives of type 2 diabetic families. Diabetes 49: 1169-1177, 2000.
29. Jiang G, Dallas-Yang Lui F, Moller DE, and Zhang BB. Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor α (TNFα)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney (HEK293) cells. J Biol Chem 278: 180-186, 2003.
30. Kanety H, Feinstein R, Papa MZ, Hemi R, and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270: 23780-23784, 1995.
31. Kim Y-B, Nikoulina SE, Ciaraldi TP, Henry RR, and Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741, 1999.
32. Kim JK, Kim Y-J, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, and Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108: 437-446, 2001.
33. Krook A, Björnholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, and Zierath JR. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49: 284-292, 2000.
34. Krützfeldt J, Kausch C, Volk A, Klein HH, Rett K, Häring HU, and Stumvoll M. Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes 49: 992-998, 2000.
35. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, and Kadowaki T. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49: 1880-1889, 2000.
36. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, and Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87: 2128-2133, 2002.
37. Legro RS, Kunselman A, Dodson WC, and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84: 165-169, 1999.
38. Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA, Zhang BB, and Evans JL. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 87: 4088-4093, 2002.
39. McIntyre EA, Halse R, Yeaman SJ, Walker M. Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake. J Clin Endocrinol Metab 89: 3440-3448, 2004.
40. Modan M, Harris MI, and Halkin H. Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes 38: 1630-1635, 1989.
41. Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, and Henry RR. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. J Clin Endocrinol Metab 86: 4307-4314, 2001.
42. Nilsson C, Niklasson M, Eriksson E, Bjorntorp P, and Holmang A. Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J Clin Invest 101: 74-78, 1998.
43. Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, and Beguinot F. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 40: 421-429, 1997.
44. Reynolds NJ, Baldassare JJ, Henderson PA, Shuler JL, Ballas LM, Burns DJ, Moomaw CR, and Fisher GJ. Translocation and downregulation of protein kinase C isoenzymes-alpha and -epsilon by phorbol ester and bryostatin-1 in human keratinocytes and fibroblasts. J Invest Dermatol 103: 364-369, 1994.
45. 307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
46. Sarabia V, Lam L, Burdett E, Leiter LA, and Klip A. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest 90: 1386-1395, 1992.
47. Tanti JF, Gremeaux T, van Obberghen E, and Le Marchand-Brustel Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269: 6051-6057, 1994.
48. Thompson DB, Prately R, and Ossowski V. Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action. J Clin Invest 98: 2346-2350, 1996.
49. Vollenweider P, Ménard B, and Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (ζ/λ) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 51: 1052-1059, 2002.
50. Youngren J, Goldfine ID, and Pratley RE. Decreased insulin receptor kinase correlates with insulin resistance in normoglycemic Pima Indians. Am J Physiol Endocrinol Metab 273: E276-E283, 1997.
51. Youngren JF, Goldfine ID, and Pratley RE. Insulin receptor autophosphorylation in cultured myoblasts correlates to glucose disposal in Pima Indians. Am J Physiol Endocrinol Metab 276: E990-E994, 1999.
52. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.